Literature DB >> 13940914

[Skin hypersensitivity to purified myelin antigen in neurological diseases, with special reference to multiple sclerosis].

G PAAL, D BOEHME, H KERSTEN, W KERSTEN.   

Abstract

Entities:  

Keywords:  ANTIGENS; MULTIPLE SCLEROSIS

Mesh:

Substances:

Year:  1963        PMID: 13940914

Source DB:  PubMed          Journal:  Dtsch Z Nervenheilkd        ISSN: 0367-004X


× No keyword cloud information.
  8 in total

1.  The passive transfer of experimental allergic encephalomyelitis and neuritis with living lymphoid cells.

Authors:  K E ASTROM; B H WAKSMAN
Journal:  J Pathol Bacteriol       Date:  1962-01

2.  [Chemical & serological studies in multiple sclerosis].

Authors:  H BAUER; R HEITMANN
Journal:  Dtsch Z Nervenheilkd       Date:  1958

3.  The transfer of experimental allergic encephalomyelitis in the rat by means of parabiosis.

Authors:  M M LIPTON; J FREUND
Journal:  J Immunol       Date:  1953-11       Impact factor: 5.422

4.  [On the serology of "experimental allergic neuritis". An agar precipitation test with alcoholic nerve extracts].

Authors:  B NIEDIECK; K LANKEN
Journal:  Klin Wochenschr       Date:  1961-11-15

5.  Proteolipides, a new type of tissue lipoproteins; their isolation from brain.

Authors:  J FOLCH; M LEES
Journal:  J Biol Chem       Date:  1951-08       Impact factor: 5.157

6.  OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS.

Authors:  T M Rivers; D H Sprunt; G P Berry
Journal:  J Exp Med       Date:  1933-06-30       Impact factor: 14.307

7.  ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS.

Authors:  T M Rivers; F F Schwentker
Journal:  J Exp Med       Date:  1935-04-30       Impact factor: 14.307

8.  Acute disseminated encephalomyelitis following immunization with homologous brain extracts; studies on the role of a circulating antibody in the production of the condition in dogs.

Authors:  L THOMAS; P Y PATERSON; B SMITHWICK
Journal:  J Exp Med       Date:  1950-08       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.